Avda. De los Reyes, 1
28770 - Colmenar Viejo
Madrid, Spain
Phone: +34 91 846 6000
Fax: 91 846 6001
Alfonso Ortín
Comunications Director
aortin@pharmamar.com
Miguel Martínez-Cava
Communication Manager
mmartinez-cava@pharmamar.com
Álvaro Mateo
Communication Manager
amateo@pharmamar.com
Pharmacovigilance Contact Information to report an adverse reaction* or special situation**:
- Email: phv@pharmamar.com
- Fax: +34 91 846 60 04
For any notification, please provide:
- Information that identifies the person that reports the information: name, contact information (Email, Phone number, Fax, or Mail address)
- Information that identifies the person exposed to the drug and who experienced the adverse reaction or special situation**: sex, age
- PharmaMar company drug to which the person has been exposed
- Adverse reaction or the special situation** that the person experienced
* Adverse reaction: An adverse reaction is a response to a medicinal product which is noxious and unintended [DIR Art 1].
**Special situations: overdose/medication errors/abuse/off-label use/pregnancy exposure (mother or father)/breastfeeding exposure/suspicion of the infectious agent transmission/lack of efficacy/unexpected clinical or therapeutic benefit/occupational exposure.
José Luis Moreno
Capital Markets & Investor Relations Director
María Marín de la Plaza
Capital Markets & Investor Relations
Plaza del Descubridor Diego de Ordás, 3, planta 5
28003, Madrid, Spain
More information:
Tel 1: +34 914 44 45 00
Tel 2: +34 902 10 19 00